SINOVAC Quadrivalent Influenza Vaccine Authorized for Commercialization in the Dominican Republic
Under cooperation with local partner Biotech Boma, SINOVAC received the Sanitary Registration Certificate issued by the Ministry of Public Health and Social Assistance of the Dominican Republic, to commercialize its QIV vaccine in the country.
United States Dominican Republic Republic Of Chile Pablo Gonza Pontificia Universidad Cato Andreas Vicari
Source: pressreleasepoint.com